RE: Who are these people ?19 Oct 2020 21:50
LIMITATIONS OF THE PROCEDURE
1.Clinical performance was evaluated with frozen samples, and test performance may be different with fresh samples.
2.Users should test specimens as quickly as possible after specimen collection.
3.Positive test results do not rule out co-infections with other pathogens.
4.Results from SARS-CoV-2 Antigen Rapid Qualitative Test should be correlated with the clinical history, epidemiological data, and other data available to the clinician evaluating the patient.
5.A false-negative test result may occur if the level of viral antigen in a sample is below the detection limit of the test or if the sample was collected or transported improperly; therefore, a negative test result does not eliminate the possibility of SARS-CoV-2 infection.
6.The amount of antigen in a sample may decrease as the duration of illness increases. Specimens collected after day 5 of illness are more likely to be negative compared to a RT- PCR assay. LIMITATIONS OF THE PROCEDURE
1.Clinical performance was evaluated with frozen samples, and test performance may be different with fresh samples.
2.Users should test specimens as quickly as possible after specimen collection.
3.Positive test results do not rule out co-infections with other pathogens.
4.Results from SARS-CoV-2 Antigen Rapid Qualitative Test should be correlated with the clinical history, epidemiological data, and other data available to the clinician evaluating the patient.
5.A false-negative test result may occur if the level of viral antigen in a sample is below the detection limit of the test or if the sample was collected or transported improperly; therefore, a negative test result does not eliminate the possibility of SARS-CoV-2 infection.
6.The amount of antigen in a sample may decrease as the duration of illness increases. Specimens collected after day 5 of illness are more likely to be negative compared to a RT- PCR assay.
Sign In
Follow the stocks
